-
Cy5-UTP for Spatial RNA Trafficking Assays
2026-08-28
Cy5-UTP enables direct, spectrally defined RNA probe synthesis for FISH and neuronal RNA-trafficking studies. This article explains how to translate axonal transport findings into rigorous fluorescence assay design while separating probe signal from biological interpretation.
-
TMRE Assay Kit: Reading ΔΨm in Na+ Stress
2026-08-27
The TMRE mitochondrial membrane potential assay kit turns ΔΨm into a practical readout of mitochondrial injury, with special relevance to sodium-driven energy failure. This article connects TMRE interpretation, CCCP validation, and experimental design to the mechanism of NECSO described in recent Nature Communications research.
-
AMPK’s Dual Role in Autophagy Under Energy Stress
2026-08-26
The reference study challenges the prevailing view that AMPK uniformly activates autophagy during glucose deprivation. Using direct measurements of ULK1 activity and autophagy-initiation signaling, the authors show that AMPK suppresses autophagy during acute energy crisis while preserving the ULK1-associated machinery needed for recovery.
-
AG-221 (Enasidenib) Workflow for IDH2 AML
2026-08-26
AG-221 and Enasidenib provide a practical pharmacological handle for testing mutant-IDH2 biology, 2-hydroxyglutarate reduction, and leukemia cell differentiation in controlled AML models. This workflow extends beyond viability by connecting oncometabolite suppression to CD44-dependent metabolic rewiring, resistance, and combination hypotheses.
-
Pyridostatin: From G-Quadruplexes to Translation
2026-08-26
Pyridostatin TFA offers translational researchers a practical chemical entry point into G-quadruplex biology. This article connects its established role in telomere dysfunction and cancer models with emerging evidence that RNA G-quadruplexes influence TDP-43 condensation and toxicity, while defining the experimental boundaries that must be respected before moving toward therapeutic claims.
-
Tetrahydromagnolol in GPCR Assay Design
2026-08-25
Tetrahydromagnolol is a selective peripheral CB2 receptor agonist for mechanism-focused cannabinoid receptor research. This article develops a pathway-aware assay strategy that distinguishes CB2 pharmacology from TBXA2R–ERM signaling rather than treating GPCR-driven migration as a single mechanism.
-
From Ox-mtDNA to Actionable Viability Data
2026-08-24
A mechanistic and translational framework for connecting the ex-histone–mitochondria–IRF1–NLRC5 axis in lung ischemia–reperfusion injury with carefully interpreted cell viability data using Cell Counting Kit-8 (CCK-8) Plus.
-
Cell Cycle Assay Kit for Leukemia Research
2026-08-24
Turn DNA content into an actionable map of cell cycle arrest, replication, and apoptosis in leukemia and other disease models. This workflow combines PI/RNase A staining with singlet-aware flow cytometry and troubleshooting strategies for more defensible cell cycle progression analysis.
-
CX-4945 (Silmitasertib): CK2 to Translation
2026-08-23
CX-4945 (Silmitasertib) offers a mechanistically defined route to interrogate CK2-dependent survival, cell-cycle, and inflammatory signaling. This thought-leadership analysis connects established oncology workflows with emerging evidence that CSNK2A1/CK2 contributes to post-ischemic neuroinflammation, while separating validated findings from translational hypotheses.
-
Annexin V-APC/7-AAD in Epigenetic Therapy
2026-08-22
A translational framework for using the Annexin V-APC/7-AAD Apoptosis Kit to connect epigenetic drug response with phosphatidylserine exposure, membrane integrity, and mechanistic validation in MLL-rearranged leukemia models.
-
GDC-0068 Workflow for PI3K/Akt/mTOR Assays
2026-08-21
GDC-0068 (RG7440) offers a practical pan-AKT perturbation strategy for genotype-aware cancer signaling assays. This workflow connects dose response, phosphosite interpretation, cell-fate measurements, and spatial mTORC1 questions while highlighting formulation and troubleshooting choices that improve reproducibility.
-
TG003 Cdc2-like Kinase Inhibitor: Workflow Guide
2026-08-20
TG003 enables rapid, reversible control of Clk-dependent serine/arginine-rich protein phosphorylation for alternative splicing and exon-skipping experiments. This workflow also shows how to test Clk2-linked platinum resistance while separating family-wide pharmacology from gene-specific conclusions.
-
MK-2206 Dihydrochloride: Akt Assay Workflows
2026-08-20
Build cleaner Akt-pathway experiments with MK-2206 dihydrochloride, from phosphorylation time courses to apoptosis and drug-combination studies. The workflow also shows how to use Akt inhibition as a mechanistic control when studying Wnt-driven glycolysis and osteoblast differentiation.
-
TBXA2R–ERM Signaling in TNBC Metastasis
2026-08-19
The reference study identifies TBXA2R as a GPCR that activates ezrin, radixin, and moesin through coordinated G-protein, Rho GTPase, and kinase signaling. This TBXA2R–ERM axis promotes triple-negative breast cancer cell motility, invasion, and metastatic colonization, providing a mechanistic link between receptor signaling and the cytoskeletal programs that support metastasis.
-
Flubendazole: Translational Autophagy Strategy
2026-08-19
A thought-leadership perspective on using Flubendazole to connect autophagy biology with metabolic state, assay rigor, and translational decision-making across cancer, fibrosis, and neurodegeneration research.